Alex Wu
South Miami, FLNPI 1952989063
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,108 of the $1,340 with a category attached, or 82.6%. It is spread thinly across 24 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $723, more than ten times the $15 reported in 2021.
Across 54 payments — averaging $24.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$212
- Lilly USA, LLC$192
- Merck$105
- Pfizer$103
- Takeda Pharmaceuticals U.S.A., Inc.$77
- Seagen Inc.$75
- plus $576 from 18 others
What the payments were for
- Food & beverage$1,10883%
- Education$23317%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $212 |
| Lilly USA, LLC | 6 | $192 |
| Merck | 5 | $105 |
| Pfizer | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Seagen Inc. | 1 | $75 |
| Novartis | 3 | $68 |
| Daiichi Sankyo Inc. | 3 | $68 |
| GSK | 3 | $64 |
| Sobi, Inc | 2 | $62 |
| Eisai Inc. | 2 | $43 |
| Beone Medicines USA, Inc. | 1 | $30 |
| Springworks Therapeutics, Inc. | 1 | $25 |
| Mirati Therapeutics, Inc. | 1 | $24 |
| Exact Sciences | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| AbbVie | 1 | $20 |
| Tempus AI, Inc | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| Novo Nordisk | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Inari Medical, Inc. | 1 | $15 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 17 | $153 |
| Atorvastatin Calcium | 23 | $123 |
| Lisinopril | 14 | $78 |
| Pantoprazole Sodium | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.